Skip to main content

. 1954 Mar;33(3):400–409. doi: 10.1172/JCI102912

Abnormalities of Copper Metabolism in Wilson's Disease and Their Relationship to the Aminoaciduria

A G Bearn ¹, H G Kunkel ¹

PMCID: PMC1072519 PMID: 13143088

401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
Cooper A. M., Eckhardt R. D., Faloon W. W., Davidson C. S. INVESTIGATION OF THE AMINOACIDURIA IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION): DEMONSTRATION OF A DEFECT IN RENAL FUNCTION. J Clin Invest. 1950 Mar;29(3):265–278. doi: 10.1172/JCI102254. [DOI] [PMC free article] [PubMed] [Google Scholar]
DENNY-BROWN D., PORTER H. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease). N Engl J Med. 1951 Dec 13;245(24):917–925. doi: 10.1056/NEJM195112132452401. [DOI] [PubMed] [Google Scholar]
Eden A., Green H. H. Micro-determination of copper in biological material. Biochem J. 1940 Sep;34(8-9):1202–1208. doi: 10.1042/bj0341202. [DOI] [PMC free article] [PubMed] [Google Scholar]
GUBLER C. J., LAHEY M. E., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. IX. The transportation of copper in blood. J Clin Invest. 1953 May;32(5):405–414. doi: 10.1172/JCI102752. [DOI] [PMC free article] [PubMed] [Google Scholar]
HOLMBERG C. G., LAURELL C. B. Oxidase reactions in human plasma caused by coeruloplasmin. Scand J Clin Lab Invest. 1951;3(2):103–107. doi: 10.3109/00365515109060581. [DOI] [PubMed] [Google Scholar]
KUNKEL H. G., SLATER R. J. Zone electrophoresis in a starch supporting medium. Proc Soc Exp Biol Med. 1952 May;80(1):42–44. doi: 10.3181/00379727-80-19516. [DOI] [PubMed] [Google Scholar]
LAHEY M. E., GUBLER C. J., CARTWRIGHT G. E., WINTROBE M. M. Studies on copper metabolism. VII. Blood copper in pregnancy and various pathologic states. J Clin Invest. 1953 Apr;32(4):329–339. doi: 10.1172/JCI102743. [DOI] [PMC free article] [PubMed] [Google Scholar]
MATTHEWS W. B., MILNE M. D., BELL M. The metabolic disorder in hepato-lenticular degeneration. Q J Med. 1952 Oct;21(84):425–446. [PubMed] [Google Scholar]
SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
SIDBURY J. B., Jr, BYNUM J. C., FETZ L. L. Effect of chelating agent on urinary lead excretion; comparison of oral and intravenous administration. Proc Soc Exp Biol Med. 1953 Feb;82(2):226–228. doi: 10.3181/00379727-82-20073. [DOI] [PubMed] [Google Scholar]
STEIN W. H., BEARN A. G., MOORE S. The amino acid content of the blood and urine in Wilson's disease. J Clin Invest. 1954 Mar;33(3):410–419. doi: 10.1172/JCI102913. [DOI] [PMC free article] [PubMed] [Google Scholar]
UZMAN L. L., HOOD B. The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration). Am J Med Sci. 1952 Apr;223(4):392–400. doi: 10.1097/00000441-195204000-00006. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES